PHASTER 研究:皮下注射 (SC) 培妥珠单抗和曲妥珠单抗固定剂量复方制剂(PH FDC SC)治疗 HER2+ 乳腺癌患者的经济和组织影响

Elisabetta Munzone, A. Fabi, Giuseppe Buono, R. Caputo, Emilia Montagna, Mara Negri, Francesco Nuzzo, Antonella Palazzo, Ida Paris, Luca Conti, Anna Baggi, Jean Marie Franzini, M. de Laurentiis
{"title":"PHASTER 研究:皮下注射 (SC) 培妥珠单抗和曲妥珠单抗固定剂量复方制剂(PH FDC SC)治疗 HER2+ 乳腺癌患者的经济和组织影响","authors":"Elisabetta Munzone, A. Fabi, Giuseppe Buono, R. Caputo, Emilia Montagna, Mara Negri, Francesco Nuzzo, Antonella Palazzo, Ida Paris, Luca Conti, Anna Baggi, Jean Marie Franzini, M. de Laurentiis","doi":"10.1007/s40267-023-01038-5","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":267536,"journal":{"name":"Drugs & Therapy Perspectives","volume":"25 10","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The PHASTER Study: Economic and Organizational Impact of Subcutaneous (SC) Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Treatment of HER2+ Breast Cancer Patients\",\"authors\":\"Elisabetta Munzone, A. Fabi, Giuseppe Buono, R. Caputo, Emilia Montagna, Mara Negri, Francesco Nuzzo, Antonella Palazzo, Ida Paris, Luca Conti, Anna Baggi, Jean Marie Franzini, M. de Laurentiis\",\"doi\":\"10.1007/s40267-023-01038-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":267536,\"journal\":{\"name\":\"Drugs & Therapy Perspectives\",\"volume\":\"25 10\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drugs & Therapy Perspectives\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s40267-023-01038-5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drugs & Therapy Perspectives","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40267-023-01038-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The PHASTER Study: Economic and Organizational Impact of Subcutaneous (SC) Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Treatment of HER2+ Breast Cancer Patients
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Suspect cutaneous lupus erythematous in older patients with photosensitive rash Evaluation of the Med Safety mobile app for reporting adverse events in Burkina Faso Sovateltide in cerebral ischaemic stroke: a profile of its use Adis summary of research: Omalizumab in severe asthma: effect on oral corticosteroid exposure and remodelling. A randomized open-label parallel study Management of psychosis in the course of cushing syndrome: a review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1